Literature DB >> 1325433

WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. no. 89009. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

S Miyata1, N Ohhata, H Murai, Y Masui, M Ezaki, S Takase, M Nishikawa, S Kiyoto, M Okuhara, M Kohsaka.   

Abstract

WS009 A and B novel endothelin receptor antagonists, have been isolated from the fermentation broth of Streptomyces sp. No. 89009. These antagonists were purified from the culture filtrate followed by Diaion SP-207, DEAE Toyopearl column chromatography and HPLC. WS009 A and B showed selective activity in an endothelin receptor binding assay with IC50 of 5.8 x 10(-6) M and 6.7 x 10(-7) M, respectively. On the basis of spectroscopic and chemical evidence, the structures of WS009 A and B have been established as 1 and 3, and are highly hydroxylated benz[a]anthraquinone chromophores.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325433     DOI: 10.7164/antibiotics.45.1029

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics.

Authors:  Mamta Rawat; Gerald L Newton; Mary Ko; Gladys J Martinez; Robert C Fahey; Yossef Av-Gay
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Discovery of Mycothiogranaticins from Streptomyces vietnamensis GIMV4.0001 and the Regulatory Effect of Mycothiol on the Granaticin Biosynthesis.

Authors:  Ming-Rong Deng; Yan Li; Xiao Luo; Xiang-Ling Zheng; Yuchan Chen; Yu-Lian Zhang; Weimin Zhang; Hao Zhou; Honghui Zhu
Journal:  Front Chem       Date:  2021-12-23       Impact factor: 5.221

3.  Identification, Cloning and Heterologous Expression of the Gene Cluster Directing RES-701-3, -4 Lasso Peptides Biosynthesis from a Marine Streptomyces Strain.

Authors:  Daniel Oves-Costales; Marina Sánchez-Hidalgo; Jesús Martín; Olga Genilloud
Journal:  Mar Drugs       Date:  2020-05-01       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.